INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
8.04
-0.20 (-2.43%)
Apr 24, 2025, 4:00 PM EDT - Market closed
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $184.36 million as of April 25, 2025. Its market cap has decreased by -2.74% in one year.
Market Cap
184.36M
Enterprise Value
163.82M
1-Year Change
-2.74%
Ranking
Category
Stock Price
$8.04
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has increased from $77.82M to $184.36M, an increase of 136.89%. That is a compound annual growth rate of 14.87%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.57B |
| UnitedHealth Group | 387.15B |
| Johnson & Johnson | 378.15B |
| AbbVie | 301.01B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |